Saxon Gayo, 60, a lung cancer survivor, shared his story during a proclamation signing at Adelup on Friday, advocating for ...
Background Compared with cytotoxic chemotherapy, the efficacy and safety of immune checkpoint inhibitors (ICIs) for patients ...
Trodelvy reduced progression or death risk by 51% compared to chemotherapy in EGFR-mutated non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors. The median progression-free survival ...
Overall survival (OS) data, published simultaneously by the Journal of Clinical Oncology, 2 show the longest survival data ...
Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo –– ...
Among patients with small cell lung cancer (SCLC), treatment with Imdelltra (tarlatamab-dlle) was found to improve overall ...
Medpage Today on MSN
'Blow Your Mind' Survival Improvement in Advanced, Mutated NSCLC
BERLIN -- Almost half of patients with advanced ALK -positive non-small cell lung cancer (NSCLC) have lived 7 years or longer ...
To improve the quality of life of people with cancer, oncologists have regularly recommended exercise. “The thinking in the ...
To improve the quality of life of people with cancer, oncologists have regularly recommended exercise. Staying fit can make ...
Advocates for cancer research and resources put aside political differences to lobby lawmakers on Capitol Hill.
I wake up every morning and thank the Lord to be alive again,” says Ron Roy, 80, from his home in Kelowna. “I hope to make it to 100. My grandmother made it to one month shy of her 100th birthday.” ...
In a rally outside the U.S. Department of Labor, miners and their advocates stressed the need to limit silica exposure and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback